A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2 Expressing Breast or Gastric/Stomach Cancers
Interventions: BIOLOGICAL: MEDI4276
Sponsor: MedImmune LLC